Bio-Path Holdings, Inc. - Common Stock (BPTH)
0.8074
-0.0085 (-1.04%)
Bio-Path Holdings is a biotechnology company focused on the development of innovative cancer therapies that utilize its proprietary DNA-based drug delivery platform
The company’s main objective is to create and advance treatments that enhance the effectiveness of existing cancer treatments while reducing side effects. By leveraging its proprietary technology, Bio-Path aims to deliver therapeutic agents directly to cancer cells, thereby improving treatment outcomes and addressing unmet medical needs in oncology. The company is committed to advancing its drug candidates through clinical trials and collaboration with research institutions to bring new hope to patients battling cancer.
Frequently Asked Questions
Is Bio-Path Holdings, Inc. - Common Stock publicly traded?
Yes, Bio-Path Holdings, Inc. - Common Stock is publicly traded.
What exchange does Bio-Path Holdings, Inc. - Common Stock trade on?
Bio-Path Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bio-Path Holdings, Inc. - Common Stock?
The ticker symbol for Bio-Path Holdings, Inc. - Common Stock is BPTH on the Nasdaq Stock Market
What is the current price of Bio-Path Holdings, Inc. - Common Stock?
The current price of Bio-Path Holdings, Inc. - Common Stock is 0.8074
When was Bio-Path Holdings, Inc. - Common Stock last traded?
The last trade of Bio-Path Holdings, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Bio-Path Holdings, Inc. - Common Stock?
The market capitalization of Bio-Path Holdings, Inc. - Common Stock is 3.48M
How many shares of Bio-Path Holdings, Inc. - Common Stock are outstanding?
Bio-Path Holdings, Inc. - Common Stock has 4.31M shares outstanding.